Resmed (RMD) Income from Continuing Operations (2009 - 2026)
Resmed's Income from Continuing Operations came in at $383.43 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 1.0% from $379.71 million a year earlier but down 3.8% from the prior quarter.
Powered by 
Analysis
Resmed (RMD) Income from Continuing Operations (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Resmed's Income from Continuing Operations was $1.52 billion, up 8.8% from FY2025.
- Income from Continuing Operations has increased in each of the last five fiscal years, with a five-year compound annual growth rate of 26.3% (FY2021 to FY2026).
- Going back by fiscal year, Income from Continuing Operations was $1.4 billion in FY2025 (+37.2%), $1.02 billion in FY2024 (+13.7%), $897.56 million in FY2023 (+15.2%) and $779.44 million in FY2022 (+64.3%).
- The five-year range for quarterly Income from Continuing Operations is $179.01 million (fiscal Q3 2022) to $398.73 million (fiscal Q3 2026).
- Year-over-year, Income from Continuing Operations has increased for ten consecutive quarters, with growth averaging 24.3% over the last eight quarters.
- The fastest year-over-year change in Income from Continuing Operations over five years came in fiscal Q2 2025 (growth of 65.0%), and the weakest in fiscal Q2 2024 (a decline of 7.2%).
- Business Quant data shows RMD's Income from Continuing Operations at $398.73 million (Q3 2026), $392.59 million (Q2 2026) and $348.54 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 1.74 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 920.00 Mn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 1.21 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 524.40 Mn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 1.48 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | -237.00 Mn |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 580.00 Mn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 301.40 Mn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 318.00 Mn |
| 10 | Resmed | 32.93 Bn | 27.37 Bn | 870.57 Mn | 418.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 418.41 Mn |
| Jun 30, 2026 | 383.43 Mn |
| Mar 31, 2026 | 398.73 Mn |
| Dec 31, 2025 | 392.59 Mn |
| Sep 30, 2025 | 348.54 Mn |
| Jun 30, 2025 | 379.71 Mn |
| Mar 31, 2025 | 365.04 Mn |
| Dec 31, 2024 | 344.62 Mn |
| Sep 30, 2024 | 311.36 Mn |
| Jun 30, 2024 | 292.24 Mn |
| Mar 31, 2024 | 300.49 Mn |
| Dec 31, 2023 | 208.80 Mn |
| Sep 30, 2023 | 219.42 Mn |
| Jun 30, 2023 | 229.66 Mn |
| Mar 31, 2023 | 232.50 Mn |
| Dec 31, 2022 | 224.91 Mn |
| Sep 30, 2022 | 210.48 Mn |
| Jun 30, 2022 | 195.06 Mn |
| Mar 31, 2022 | 179.01 Mn |
| Dec 31, 2021 | 201.75 Mn |
API Access
Resmed Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();